What is NDC 72888-268?

72888-268 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, listed with the FDA by Advagen Pharma Ltd.,. It has 3 package NDCs, shown above in 10- and 11-digit form.

Advagen Pharma Ltd.,, NDC labeler code 72888. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pentoxifylline?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pentoxifylline NDC 72888-268 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-268Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0268Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72888-268-01	72888026801	30 TABLET in 1 BOTTLE (72888-268-01)Marketed from Oct 1, 2026
72888-268-02	72888026802	100 TABLET in 1 BOTTLE (72888-268-02)Marketed from Oct 1, 2026
72888-268-03	72888026803	500 TABLET in 1 BOTTLE (72888-268-03)Marketed from Oct 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pentoxifylline
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Ltd.,NDC labeler code 72888
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 018631
Marketing start: Oct 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 72888-268_5b32a4ae-24c9-c81c-e063-6394a90a867dSPL ID 5b32a4ae-24c9-c81c-e063-6394a90a867d
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888026801 followed by a unit qualifier and the quantity

Package 72888-0268-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 72888-268

What is NDC 72888-268?: 72888-268 is the product NDC for Pentoxifylline, Pentoxifylline 400 mg/1 tablet, listed with the FDA by Advagen Pharma Ltd.,. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pentoxifylline.
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Advagen Pharma Ltd.,, NDC labeler code 72888. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pentoxifylline?: 7 other product NDCs are listed under this name. See all Pentoxifylline NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pentoxifylline NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	71335-2586	71335-2586-0171335-2586-0271335-2586-03
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Rising Pharma Holdings, Inc.	16571-856	16571-0856-0116571-0856-0516571-0856-11+2 more
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8511	00615-8511-39
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	ANI Pharmaceuticals, Inc.	70954-668	70954-0668-1070954-0668-20
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-0033	60505-0033-0660505-0033-07
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Major Pharmaceuticals	0904-5448	00904-5448-61
Pentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Bryant Ranch Prepack	63629-2910	63629-2910-0163629-2910-0263629-2910-03

Other NDCs under NDA 018631

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018631
Product	Strength	Form · route	Labeler	Product NDC
Trentalpentoxifylline	Pentoxifylline 400 mg/1	Tablet, Extended releaseOral	Validus Pharmaceuticals LLC	30698-006